When analyzed by treatment class (data were available for 126 patients), anti-CD74 levels were numerically higher in csDMARD-treated patients (n = 106) compared to untreated individuals (n = 20) (median 12.5 vs 10.5 U/mL); however, this difference did not reach statistical significance (p = 0.053).
← all excerpts
IgA anti-CD74 autoantibodies are associated with treatment escalation in peripheral psoriatic arthritis.
1
0.0530
0.0530